NASDAQ:EIGR - Eiger Biopharmaceuticals Price Target & Analyst Ratings

+0.24 (+2.20 %)
(As of 07/16/2019 04:00 PM ET)
Today's Range
Now: $11.16
50-Day Range
MA: $10.69
52-Week Range
Now: $11.16
Volume82,769 shs
Average Volume182,412 shs
Market Capitalization$214.94 million
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Eiger Biopharmaceuticals (NASDAQ:EIGR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Eiger Biopharmaceuticals in the last 12 months. Their average twelve-month price target is $30.8171, suggesting that the stock has a possible upside of 176.14%. The high price target for EIGR is $47.00 and the low price target for EIGR is $10.72. There are currently 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.8171$36.60$34.1429$34.00
Price Target Upside: 176.14% upside230.32% upside140.10% upside227.24% upside

Eiger Biopharmaceuticals (NASDAQ:EIGR) Consensus Price Target History

Eiger Biopharmaceuticals (NASDAQ:EIGR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/26/2019KeyCorpInitiated CoverageOverweight$22.00 ➝ $10.72LowView Rating Details
6/26/2019CitigroupInitiated CoverageBuy$22.00 ➝ $22.00LowView Rating Details
6/18/2019WedbushReiterated RatingOutperform$35.00LowView Rating Details
6/18/2019LADENBURG THALM/SH SHReiterated RatingBuy$28.00HighView Rating Details
1/28/2019Robert W. BairdInitiated CoverageOutperform$47.00MediumView Rating Details
12/19/2018BTIG ResearchBoost Price TargetBuy$44.00 ➝ $47.00HighView Rating Details
10/18/2018OppenheimerSet Price TargetBuy$26.00MediumView Rating Details
5/30/2018Piper Jaffray CompaniesReiterated RatingOverweight$24.00LowView Rating Details
5/9/2018B. RileyInitiated CoverageBuy ➝ Buy$24.00HighView Rating Details
10/19/2017Roth CapitalInitiated CoverageBuy ➝ Buy$35.00N/AView Rating Details
(Data available from 7/16/2017 forward)
This page was last updated on 7/16/2019 by Staff

Featured Article: CD Ladder

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel